Keros Therapeutics
KROS
$57.10
Share price
-1.07%
Change (1 day)
23.94%
Change (1 year)
Categories
Keros Therapeutics (KROS) - Cash on Hand
Cash on Hand as of December 2023 : $0.33 B
According to Keros Therapeutics's latest financial reports the company has $0.33 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Keros Therapeutics - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.33 B | 18.67% |
| 2022-12-31 | $0.27 B | 21.3% |
| 2021-12-31 | $0.23 B | -13.48% |
| 2020-12-31 | $0.26 B | 3687.41% |
| 2019-12-31 | $7.02 M | -69.82% |
| 2018-12-31 | $23.25 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -37.13% | 🇺🇸 USA |